We studied item recognition in subjects administered scopolamine, a centrally-acting muscarinic acetylcholine antagonist. Eight subjects studied a set of complex visual images after administration of 0.4 mg scopolamine. Another eight subjects performed the same task without drug administration. On a subsequent item recognition test, subjects rated, on a five-point scale, their confidence that the studied pictures and an equal number of unstudied lures were actually presented. We assessed the relative contribution of familiarity and recollection to memory performance using the Yonelinas (1994) high-threshold model, a mathematical implementation of two-process theory. Results showed that scopolamine affected responses to studied items, but not unstudied lures, demonstrating an unambiguous effect of scopolamine on recognition memory. Interestingly, the Yonelinas model, while providing an excellent fit to the control data, could not adequately describe the response distribution of the scopolamine-injected subjects. To describe the scopolamine-injected subjects' data, we constructed a new model that includes the high-threshold model as a limiting case. In this model, recollection is not an allor-none process, but rather contributes gradations of confidence. Using this new model, we were able to describe the scopolamine-injected subjects' data by assuming that scopolamine affects recollection and familiarity in exactly the same way.
termine whether or not they were presented as part of the learning episode. Previous studies of muscarinic antagonist effects have found striking effects on the free recall of words. It is well-known that items studied under the influence of scopolamine are harder to recall after a delay (Crow & Grove-White, 1973; Frith, Richardson, Samuel, Crow, & McKenna, 1984; Ghoneim & Mewaldt, 1975 , 1977 . Some authors have shown that immediate recall is spared (Crow & Grove-White, 1973; Ghoneim & Mewaldt, 1975; Safer & Allen, 1971) , with the recall deficit only appearing after a delay of tens of seconds. Other authors have argued that scopolamine does not disrupt recall of items learned prior to the administration of scopolamine (Ghoneim & Mewaldt, 1977) .
In contrast to the unambiguous evidence for a recall deficit with scopolamine, the evidence regarding scopolamine's effect on recognition is much less clear. Recognition impairments have been observed for recognition of visual stimuli in monkeys (Aigner & Mishkin, 1986; Tang et al., 1997) . To this point, however, there is no unambiguous evidence for an effect of scopolamine on recognition memory in humans. Some recent studies (Richardson, Frith, Scott, Crow, & Cunningham-Owens, 1984; Mintzer & Griffiths, 2001) have observed a recognition deficit with scopolamine, but the use of lures that are semantically (Mintzer & Griffiths, 2001; Richardson et al., 1984) or phonologically related to list items make it possible to interpret these results as a consequence of altered response bias in combination with semantic or perceptual confusion, rather than a purely mnemonic effect. Many previous studies tested recognition memory for items that had been studied and previously recalled under the influence of scopolamine (Beatty, Butters, & Janowsky, 1986; Ghoneim & Mewaldt, 1975 , 1977 . Subjects in these experiments were initally presented with a list of words, then tested for free recall of the list prior to the recognition test. The recognition test, in effect, tested not only on their memory for the original encoding event, but also on their memory for their performance on the recall tests. Because recalled words are re-experienced during these recall tests, later recognition memory should be improved by the act of recalling. Because subjects administered scopolamine recall fewer words, they would be expected to get less of a benefit from the recall test. Thus, the presence of a recall deficit could lead, by itself, to a recognition deficit when sequential testing is used. Despite this confound, several groups failed to observe a significant deficit in item recognition (Beatty et al., 1986; Ghoneim & Mewaldt, 1975) , suggesting that scopolamine might have little or no effect on recognition memory (Hasselmo & Wyble, 1997) .
Episodic memory and recognition
Episodic memory is defined as memory for specific events or experiences. As we experience the world we attempt to interlink specific items or events to their corresponding spatiotemporal context. This is necessary for successful performance in episodic recall tasks, which are known to be affected by scopolamine. In typical episodic recall tasks (e.g. free recall), the individual items being encoded are not novel, but the experimental context, or situation, in which they were experienced is novel. The task, then, does not simply require memory for the specific items-all of the items are wellknown-but requires the subject to remember that the items were presented in a specific spatio-temporal context (Howard & Kahana, 1999 . Tulving (1983) characterized recognition memory as supported by two processes, familiarity and recollection. Recollection, or "remembering," is an episodic memory process which entails a conscious retrieval of a prior experience along with contextual information associated with that event. In contrast, familiarity, or "knowing" is a semantic process which does not rely on memory for spatial or temporal context. Episodic recall, which has been shown to be reliably affected by scopolamine, is closely related to recollection. Perhaps the reason that an item recognition deficit has been difficult to observe with scopolamine is that familiarity is relatively unaffected by scopolamine, and familiarity is sufficient to support near-normal performance in item recognition.
The idea that two processes support recognition memory has a long history (Atkinson & Juola, 1974; Mandler, 1980) . Atkinson and Juola (1974) argued that an initial fast familiarity process can support recognition performance. Sometimes, however, a second, slower process is also engaged. This second process, similar to recall, involves a search through memory in an attempt to retrieve specific details of the event. Similarly, Mandler (1980) argued that prior experience with an item by itself facilitates subsequent perceptual analysis, leading to a general feeling of familiarity. Like Atkinson and Juola (1974) , Mandler (1980) also argued that a search process like that involved in recall contributes to recognition performance. He introduced the idea that these two processes operate in parallel rather than in series, and that the medial temporal lobe should be specifically involved in recollection. Yonelinas (1994 Yonelinas ( , 1999 Yonelinas ( , 2001 ) has implemented dual process theory in a way that enables it to predict performance in multiple-response recognition. Rather than simply saying 'yes' or 'no' in response to recognition probes, in multipleresponse recognition, subjects rate their confidence in having previously seen a test item. The Yonelinas model assumes that old items (probes that were presented) give rise to a range of confidence ratings as a consequence of their familiarity. New items also give rise to some familiarity, but not as much as items from the prior list, which, by virtue of having been recently presented, are on average more familiar. In addition to the contribution from familiarity, recollection is assumed to take place for a subset of the old items. The qualitative nature of recollection is assumed to enable subjects to respond with certainty. Probes that cause recollection are assumed to exceed all possible response criteria, resulting in a highest-confidence 'yes' response. For this reason, we will refer to this implementation of dual process theory as the Yonelinas High Threshold model. The Yonelinas High Threshold model has been shown to successfully describe the distribution of confidence ratings under a variety of conditions (for a recent review, see Yonelinas, 2001 ).
Experiment 1
Previous results have suggested that episodic recall is specifically impaired following administration of scopolamine. There is no clear data, however, showing an effect of scopolamine on recognition. In the current experiment we used a recognition task using multiple confidence ratings as responses to examine the effects of scopolamine on recollection and familiarity using the Yonelinas High Threshold Model. If episodic recall is selectively affected by scopolamine and episodic recall corresponds to recollection, then we predict that scopolamine will impair recollective processes while leaving familiarity relatively intact.
Methods
Subjects. Eight subjects, six females and two males, participated in the scopolamine group. Their ages ranged from 19-25 (mean=22 0 ¡ 6). These subjects were recruited to participate in a cognitive drug study. Respondants spoke to the study neurologist (A. A.) who discussed with them the potential risks of participation and pre-screened them by taking a detailed medical history. Exclusion criteria included a history of neurological or psychiatric conditions, recent physical illness, ongoing or recent use of psychoactive medications, medical contraindications to anticholinergics, or any medical condition that could potentially be exacerbated by administration of anticholinergic drugs. One subject was not enrolled on the basis of the medical exclusion criteria. Drug administration and cognitive testing took place in an exam room in the Neurology Clinic of Massachusetts General Hospital (M.G.H.). Subjects administered scopolamine were paid $75 for their pariticipation.
An additional eight subjects, six females and two males, served as behavioral controls. Behavioral controls were recruited from the Boston University student community. Their ages ranged from 19-30 (mean=22 0 ¡ 1 5). Control subjects were excluded if they reported an existing psychological or neurological condition, or if they reported taking psychoactive medications. No control subjects were excluded on the basis of these criteria. Testing of control participants was conducted in a cognitive testing room at Boston University. Control participants were paid $30 for their participation. The study was approved by Institutional Review Boards at both M.G.H. and Boston University.
Materials. The stimuli for the experiment consisted of complex visual scenes similar to those used in previous imaging studies of memory encoding (Kirchhoff, Wagner, Maril, & Stern, 2000; Stern, Sherman, Kirchhoff, & Hasselmo, 2001) . The set of 604 stimuli contained equal numbers of pictures showing indoor and outdoor scenes.
Cognitive testing was administered using a Macintosh iBook computer. A four-key button box connected to the USB port of the machine was used to collect behavioral responses during the encoding phase of the experiment. Recognition testing was controlled using PsyScope.
Procedure. After obtaining informed consent, subjects in the scopolamine group underwent a detailed history, and general physical and neurological examinations. Each subjects' blood pressure, heart rate, respiratory rate, pupillary size and weight were recorded. In addition, female participants were administered a urine pregnancy test. Following this initial examination, subjects were administered scopolamine 0.4 mg (Scopolamine Hydrobromide, 0.4 mg/ml, American Pharmaceutical Partners, Inc., Los Angeles, CA 90024) via intramuscular injection in the deltoid. The weights of the injected subjects ranged from 52-82 kg (mean¢ 68 8). Cognitive testing began 90 minutes following injection. Prior work has shown that scopolamine has its maximal amnestic effect during this time period (Safer & Allen, 1971; Dundee & Pandit, 1972; Pandit & Dundee, 1970) . Subjects were continuously monitored over the next four hours. They were periodically examined with particular focus to their mental status, coordination, balance, and gait, and their blood pressures, heart rates, respiratory rates, and pupillary size changes were recorded.
A 300 picture subset of the picture pool was selected for presentation. Half of these pictures were indoor scenes and the other half were outdoor scenes. Presentation of the pictures was divided into 10 study trials, each lasting 2.5 minutes. After the first five study trials there was a 15 minute break, during which the drug-injected subjects were examined.
All stimuli were presented for 2 seconds in the center of the computer screen surrounded by a black background. The pictures occupied an area of 6 8 £ 10 23 cm on the computer screen. Subjects sat with their faces approximately 30 cm from the screen.
Presentation of fixation crosses and repeated pictures were intermixed pseuedorandomly with presentation of the 300 pictures in order to allow us to implement this design in a future fMRI study. Two pictures were repeated 75 times each during the first five trials. Another two pictures were repeated during the last five trials. The responses to these pictures are not analyzed here.
To minimize strategic effects, and to ensure that the druginjected group was attending to the stimuli, an orienting task was used during study. During the encoding phase, subjects were required to make an indoor versus outdoor discrimination for each picture by pressing one of two buttons on the button box. Subjects were instructed to make the indoor/outdoor discrimination as quickly as possible without sacrificing accuracy. They were also instructed to encode the pictures into memory in preparation for a subsequent memory test. All subjects were monitored during the orienting task and verbal prompting was used as needed.
Following the last presentation trial there was a fifteen minute delay prior to the start of the recognition test. During this delay, the drug-injected subjects were re-examined. During recognition testing, the entire set of 604 pictures was presented. Of these, 300 pictures had been presented once during study. Another 300 pictures were lures that had not been presented during study. The remaining four pictures had been presented multiple times during study. Responses to these repeated pictures were not analyzed. Subjects indicated whether each tested item was presented by pressing a number from 1-5 on the computer keyboard. A '1' response indicated that the subject was highly confident the test item was presented during the study phase. A '5' response indicated that the subject was highly confident that the test item was not presented during the study phase. Because we were concerned that a scale in which memory decreases with increasing numerical values was counterintuitive, for expository purposes, we will invert this scale for the remainder of this ms. That is, high-confidence 'yes' responses will be referred to as '5's and high-confidence no responses will be referred to as '1's, despite the fact that this does not correspond to the actual buttons the subjects pressed. Each picture remained on the screen until the subject made a valid response. We encouraged subjects to respond as quickly as possible without sacrificing accuracy. Scopolamine-injected subjects were observed for at least five hours post-injection. Following a final examination, they were escorted home.
Results and Discussion
Drug side effects. All subjects injected with scopolamine were found to have pupillary dilation, and reported mild or moderate dryness of the mouth and a perception of mild alteration in their cognitive and/or emotional state (nondysphoric). Five of the eight participants injected with scopolamine also reported feeling mildly or moderately tired. These findings are expected side effects of scopolamine in this dose range (Safer & Allen, 1971 ). None of the subjects
The left column shows the distributions of responses to new items (items not shown during encoding). The right column shows the distributions to old items (items presented during encoding). The difference between the new and old distributions is attibutable to memory. The top row shows response distributions for control subjects. The bottom row shows response distributions for subjects administered scopolamine. Error bars reflect one standard error.
were found to have abnormal coordination or gait following drug administration.
Attentional effects. To determine if scopolamine caused gross impairments in arousal, we examined performance on the orienting task. The accuracy of the control subjects was 957 . This argues that the scopolamine group was able to attend to the task and identify the pictures as well as the control group. Any observed memory deficits are therefore unlikely to be a consequence of gross attentional deficits for the scopolamine group.
Recognition Performance. Figure 1 shows response distributions to old and new items for control subjects and subjects receiving scopolamine. Qualitatively, the new item response distributions appear to be similar across groups. In contrast, the old item distributions appeared to be disrupted by scopolamine. To quantify these observations, we calculated a χ 2 using the observed variance for both the old and new distributions. While the new item distributions were not significantly different from each other
. These data suggest that scopolamine disrupts item recognition.
To illustrate the difference between the effects of scopolamine on the new distributions and the old distributions, we performed regressions comparing response proportions of the scopolamine group to those of the control group for new and old items. The results of this regression are summa- The lack of an effect of scopolamine on the new item distributions allows us to rule out several uninteresting explanations for the changes in recognition performance with scopolamine. For instance, if scopolamine were inducing a change in response criteria, i.e. a change in the meaning of a '2' response, then we would expect to see a change in the new item distribution as well as the old item distribution. Similarly, if scopolamine were inducing a change in the ability to visually discriminate the pictures, we would also expect to see an effect on the new item distribution. The fact that we observed no change in the new item distribution allows us to rule out these alternative explanations. This constitutes the first clear evidence for an effect of scopolamine on item recognition.
Qualitative effects of scopolamine. It is clear from the foregoing analyses that scopolamine-injected subjects showed a difference in their response distributions specifically for old items. The old item response distribution from control subjects showed an apparently bimodal distribution with one peak toward the center of the response continuum and another peak lying entirely on the 'sure yes' response. 1 This type of distribution gives rise to an asymmetric ROC curve, 2 which has been used to argue that a high-confidence recollection process contributes to recognition performance (Yonelinas, 1994 (Yonelinas, , 1999 . The old item response distribution for the scopolamine-injected subjects also appears bimodal. However, both of the peaks appear altered relative to the control group. The central peak (presumably corresponding to familiarity) is centered lower on the confidence axis than the corresponding peak from control subjects. The highconfidence peak (presumably corresponding to recollection) appears "spread" across multiple responses, rather than being restricted to the highest confidence 'yes' response.
This interpretation, while intriguing, would change dramatically with changes in just a few of the points in Figure 1 . Therefore, to informally assess the reliability of these qualitative changes in the old item response distributions, we examined data from individual subjects. Figure 3 shows old item response distributions from representative control and scopolamine-injected subjects. The pattern of results seen with scopolamine in the averaged data-a broadened recollective peak and a shifted familiarity-based peak-were evident in individual subjects' data as well as in the averaged data. This suggests that the pattern apparent in Figure 1 is not merely some artifact of averaging, but is a reliable description of the effect of scopolamine on responses to old items. The potential importance of these specific changes in the old item response distribution will be discussed at length in the modeling section.
Yes/No analysis. In typical item recognition experiments, subjects simply respond 'yes' or 'no' to probe items. In the present study, subjects provided multiple levels of response. In yes-no recognition, the response criteria-the amount of evidence one has to have to say 'yes'-is left to the subject. In contrast, subjects in the present study responded with multiple levels of confidence. To determine whether the discrepancy between the present results and previous failures to observe a disruption of item recognition might be attributable to these methodological differences, we re-analyzed our data as a yes-no experiment with each of four different response criteria. To give a concrete example, we could count all of the '5' responses as a 'yes' and all other responses as 'no' responses. We can use this criterion to calculate hit rates and false alarm rates for each subject. Using standard methods we can transform hits and false alarms into d Ä , as might be done in an experiment using yes-no recognition. Using this criterion, and the derived values for d Ä , we can then ask whether dÄ is greater for the subjects taking scopolamine than for the control subjects. Instead of treating '5' responses as 'yes' responses, we might have used a different criterion, treating both '4' and '5' responses as 'yes' responses, and all other levels as 'no' responses. We performed this calculation for all possible response thresholds.
The results of this analysis are shown in Table 1 . Despite the clear effect on item recognition performance observed in the response distributions (see Figure 2 ), we were unable to observe a significant difference between d Ä calculated from yes-no scoring using any response threshold criterion. Although the disruption of item recognition is dramatic when measured with graded confidence ratings (Figure 2) , it became harder to observe when using yes-no scoring. This provides a possible means to reconcile the clear effect of scopolamine on item recognition observed here with prior failures to observe such an effect.
Modeling
We modeled the resulting response distributions using the Yonelinas High Threshold model (Yonelinas, 1994 (Yonelinas, , 1999 (Yonelinas, , 2001 . In the Yonelinas model, two processes, recollection and familiarity, contribute to recognition memory performance. The initial goal of this excercise was to determine if scopolamine differentially affects recollection vs familiarity. It became necessary to consider more general models. To this end we developed a straightforward extension of the Yonelinas High Threshold model.
Methods
The Yonelinas High Threshold Model. The Yonelinas model assumes that both old and new items generate some degree of "strength." Subjects respond with a given level of confidence if the strength of the item exceeds the threshold associated with that confidence judgement. Strength comes from two sources, recollection and familiarity. Both old and new items generate familiarity, but only old items are assumed to be recollected. New item familiarity is assumed to be chosen from the normal, or Gaussian, distribution with mean µ N and standard deviation σ N , where these parameters are to be estimated from the data. Familiarity of old items is also assumed to be a random variable chosen from a normal distribution with mean µ O and standard deviation σ O . Because µ O is typically greater than µ N , familiarity can support successful recognition performance. In addition to the signal-detection based familiarity process, Yonelinas also assumes that some old items are recollected with probability R.
1 It is not quite correct to say that the two peaks observed in Figure 1 are indicative of a bimodal distribution of strength. Because the "recollective" peak includes all items with a strength that exceeds the highest-confidence criterion, the two peaks in the data could be caused by an underlying distribution that decays very slowly as strength increases.
2 An asymmetric ROC is equivalent to a nonlinear z-ROC curve.
Figure 3. The pattern of old item response distributions was observed at the individual subject level. a. Old item response distributions from representative control subjects. The presence of a putative familiarity-based peak can clearly be seen in all of the individual panels. The presence of a sharp, putative recollective peak around 'sure yes' can bee seen in three of the four subjects. The distribution in the lower left appears to show some spread in the recollective peak, consistent with a variability in the recollection process. b. Old item response distributions from scopolamine-injected subjects. All four distributions appear to show a familiarity-based peak, although one subject shows this peak around 'sure no.' Importantly, all four distributions appear to show a spread in the putative recollective peak.
These items are assumed to exceed all response criteria and are given the highest-confidence 'yes' response. So, with probability R, subjects make a 'highestconfidence yes' response to old items on the basis of recollection. With probability
Rº , subjects respond to old items on the basis of familiarity. The probability of familiarity resulting in a response that exceeds the highest response threshold is just the integral from that threshold to infinity of the familiarity distribution for old items. To find the probability that familiarity results in some other response, we need only take the integral of the underlying distribution over the appropriate interval corresponding to that response. Assuming, then, that subjects respond with the numbers 1-5, with 1 corresponding to confident 'no' and 5 being confident 'yes,' we used the following equations to estimate the proportion of responses at each level of confidence:
where N ¹ µ¿ σ¿ sº is the value of the normal distribution with mean µ and standard deviation σ evaluated at point s. The equations determing the response distributions for the new items were analogous to those for old items, with the exception that new values µ N and σ N were used, and there is no chance of recollection of items that were not previously seen:
We fit the above model of recognition performance to the average old and new response distributions by minimizing χ 2 .
An extended dual-process model. To explain the pattern of results observed under scopolamine it became necessary to extend the Yonelinas model and make specific assumptions about the effect of scopolamine on the model's performance. An assumption of the Yonelinas High Threshold model is that recollection always results in a high-confidence 'yes' response. The primary reason why the Yonelinas High Threshold model cannot describe the scopolamine group's old response distribution (Figure 1) is that it cannot accomodate the broadened recollective peak seen in that distribution. To describe this effect, we assumed that, rather than being all-ornone, recollection, like familiarity, is variable. We postulate that the distribution of strengths associated with recollection is normal with mean µ R and standard deviation σ R (see Fig-ure 4) . This straightforward generalization of the Yonelinas model gives rise to the following equations:
This expanded model includes the Yonelinas High Threshold model as a limiting case. If the entire area of the recollective distribution lies above the highest-confidence threshold, then the recollective distribution contributes only to highestconfidence 'yes' responses. Under these circumstance, the extended model simplifies to the Yonelinas High Threshold model. This occurs when µ R
The extended model adds two free parameters to the fits of the old item distributions. In adopting this expanded model, we have more free parameters describing the old item distributions than degrees of freedom in the data. It is therefore impossible to simply estimate parameters for each group and compare the resulting values. To move forward, we had to impose an additional constraint by making some specific a priori hypothesis concerning the effect of scopolamine on memory. By fitting the scopolamine and control distributions together, we can gain degrees of freedom if we use overlapping sets of parameters. Noting that the familiarity-based peak and the recollection-based peak both appear to be affected by scopolamine (see Figure 1) , we hypothesized that scopolamine acts by pushing both peaks to the left on the strength axis. This would make the variability in the recollective distribution easier to see by causing part of the recollective distribution to move below the threshold for the highestconfidence response. At the same time, it could cause the familiarity-based peak to shift to the left. In this way, a single translation could explain both of the characteristic effects of scopolamine on the old item response distributions.
To translate the strength axis, we simply shifted the means of the strength distributions by a new free parameter, S. For the old item distributions, we used
In fitting the new item distributions, we also shifted the mean of the new item distributions
The shift used in fitting the old item distribution, S old , and the shift used in fitting the new item distribution, S new , were estimated separately. In contrast, the Yonelinas High Threshold model assumes that familiarity gives rise to a range of strengths (the distribution F). In a simple generalization of the Yonelinas model, we assumed that recollection also gives rise to a distribution of strengths (the distribution R). If the recollective distribution lies sufficiently far above the highest-confidence threshold, the Yonelinas High Threshold model is recovered. To describe the effect of scopolamine, we assumed that both distributions were shifted to the left by the same amount. Results and Discussion Figure 5 . Fits of the Yonelinas High Threshold model to the data from the current experiment. Emprical data is in black. Model predictions are in grey. Layout is as in Figure 1 . Error bars are standard errors.
control subjects and subjects receiving scopolamine. Consistent with a wealth of prior modeling work, the Yonelinas High Threshold model also does a good job of describing control subjects' distribution of responses to the old items. The model captures the broad central peak attributable to familiarity-based recognition. The model also captures the high-confidence peak, attributable within the model to a recollective contribution to recognition performance. In contrast to its success in describing the control subjects' old item response distribution, the Yonelinas High Threshold model fails to capture the basic features of the scopolamine group's old item response distribution. The model places the central peak too far to the right on the strength axis. This is apparently in an attempt to compensate for the model's inability to describe the breadth of the putative recollection-based peak. In order to fit the scopolamine-injected subjects' old item distributions, it is necessary to relax some of the Yonelinas High Threshold model's assumptions. The breadth of the peak in the scopolamine-injected subjects' old item distribution suggests that recollection is not an all-or-none process under scopolamine. One possibility, then, is to simply assume that rather than generating a 'sure yes' response, recollection generates a strength from a distribution with some mean and standard deviation. In particular, the breadth of the peak could result from a decrease in the mean of the recollective distribution and/or an increase in the variability associated with it.
Examining Figure 1 it appears that, in addition to the effect on the recollective peak, the familiarity-based peak is also affected. The data provides little evidence that scopolamine dissociates recollection from familiarity, as we had initially expected. Perhaps scopolamine has a correlated effect on recollection and familiarity. Whatever the source of the correlation, it is straightforward enough to model a correlated effect of scopolamine on the old distribution in the average data. As described in the methods, we assumed that recollection for the control group was governed by a normal distribution of strength with mean µ R and standard deviation σ R . We further assumed that the scopolamine had a common effect on both recollection and familiarity of old items, shifting each underlying strength distribution by an amount S old . This model has six free parameters and eight degrees of freedom in fitting the old distributions. For the new item distributions, there were three free parameters to explain eight degrees of freedom in the data.
The 
placed it a little less than one standard deviation above the highest-confidence threshold for the control subjects. Even for the control subjects, the extended model predicts that a substantial proportion of recollective responses lead to less-than-highest-confidence 'yes' responses (see Figure 3a , lower left). The value of the shift parameter obtained from fitting the old item distributions ¹ S old ¢ 0 38º was much higher that obtained from fitting the new item distributions.
In contrast to the poor fits given by the Yonelinas model to the old item distribution for scopolamine subjects, the extended model correctly predicted the qualitative changes associated with scopolamine. The familiarity-based peak was shifted to the left, as in the data. In addition, the extended model clearly accomodates a broadening of the recollective peak under scopolamine.
General Discussion
Using a recognition task with multiple confidence ratings as responses, we tested the effect of scopolamine on the ability to differentiate previously-studied from previouslyunstudied items. Scopolamine disrupted memory for studied items, while leaving the distribution of responses to unstudied items unchanged. This is, to our knowledge, the first report of an unambiguous demonstration of a deficit in item recognition associated with scopolamine. To attempt to reconcile this finding with prior, ambiguous, results, we re-analyzed our data by scoring responses as 'yes-no' with a variety of criteria. We did not find a significant difference for any of the criteria used. This illustrates the power of confi- Figure 5 ). The scaling model assumes that recollection is not all or none, but can be described by a normal distribution. The scaling model also assumes that scopolamine affects both familiarity and recollection to the same degree. The model describes the qualitative pattern of results across conditions. In particular, the model describes the broadened recollective peak seen under scopolamine.
dence ratings to reveal subtle effects on memory.
Two-process theory (Atkinson & Juola, 1974; Mandler, 1980; Norman & O'Reilly, In revision) postulates that recognition performance is supported by two dissociable processes, recollection and familiarity. We anticipated that recollection would be more sensitive to scopolamine than familiarity. In an attempt to observe this dissociation, we modeled our data using the Yonelinas High Threshold model, a concrete implementation of dual process theory. The Yonelinas model, however, could not fit the old item distribution generated by the scopolamine group. By assuming that recollection is variable, rather than all-or-none, we extended the Yonelinas High Threshold model. Using this extended model we were able to accurately describe both control and scopolamine performance on the task by assuming that scopolamine had the same effect on both recollection and familiarity. Although we did not observe any evidence for the predicted dissociation between recollection and familiarity, this of course does not rule out the possibility that such a dissociation exists.
The observation that scopolamine affects both recollection and familiarity does not necessarily demonstrate that these cognitive processes are less separable than previously thought. It is possible that the scopolamine affects each process, but independently. Acetylcholine has many distinct physiological effects. It is also possible that scopolamine affects the transformation of memory strength into a response, or a processing stage prior to both recollection and familiarity. For instance, scopolamine might affect the representation of complex visual scenes. If representation of the items is distorted, then both components of recognition should be affected. Recollection, which presumably relies on associative processes which bind together all elements of an episode, should be ineffective if item information is corrupted and thus does not allow for extraction of commonalities within a specific event. Familiarity, which relies on a presented item's inherent memory strength relative to the strength of other similar but non-presented items, should also be impaired if item representations are distorted by scopolamine.
Another possibility is that recollection and familiarity, while functionally separable under some circumstances, rely on a common physiological mechanism that depends on the activity of acetylcholine at muscarinic receptors. Physiological evidence indicates a role for muscarinic cholinergic modulation in regions believed to be important for episodic memory (e.g. Klink & Alonso, 1997b , 1997a Fransén, Alonso, & Hasselmo, 2002) . Further, lesions of regions giving rise to cortical cholinergic innervation cause impairments in memory tasks (see review in Hagan & Morris, 1989; Numan & Quaranta Jr., 1990) . Recent work shows that selective cholinergic lesions alone do not cause strong impairments, but suggest that sparing in those cases results from the involvement of GABAergic projections from basal forebrain nuclei, as combined cholinergic and GABAergic lesions do cause impairments (Pang, Nocera, Secor, & Yoder, 2001) . Drugs that influence both cholinergic receptors (scopolamine) and GABA receptors (e.g. the benzodiazepines) have strong, and nearly indistinguishable (Ghoneim & Mewaldt, 1975 , 1977 Mintzer & Griffiths, 2001; Sperling et al., 2002) , effects on explicit memory in humans.
Theta (4-8 Hz) oscillations are a plausible common physiological target of both cholinergic and GABAergic modulation. Theta is known to play a prominent role in hippocampal physiology (Buzsáki, Leung, & Vanderwolf, 1983; Bland, 1986; Kocsis, Bragin, & Buzsáki, 1999) . Further, both GABA and acetylcholine are essential components of the septal input to the hippocampus that is necessary for theta (Wu, Shanabrough, Leranth, & Alreja, 2000) . Given the importance of the hippocampus in episodic memory (Eichenbaum, 2000; Squire & Zola, 1996) , the fact that scopolamine disrupts non-movement-related theta (or Type 2 theta as defined by Vanderwolf, 1969) in animals (Teitelbaum, Lee, & Johannessen, 1975 ) provides a possible mechanism for the effect of scopolamine on recollection. Physiological evidence suggests that theta oscillations are not limited to hippocampal regions but are also observed in entorhinal cortex (e.g. Alonso & Garcia-Austt, 1987) , anterior cingulate (Borst, Leung, & MacFabe, 1987) , and frontal regions (Ishii et al., 1999) . In addition, recent work using intracranial recording from humans has demonstrated that large-amplitude theta oscillations can be observed in a wide variety of locations in human cortex (Kahana, Sekuler, Caplan, Kirschen, & Madsen, 1999; Caplan, Kahana, Sekuler, Kirschen, & Madsen, 2000; Raghavachari et al., 2001) . It is quite possible, then, that theta is important in the function of regions that support familiarity, even if those regions prove to be separate from the medial temporal lobe regions presumed to be involved in recollection.
From a conceptual view, it makes sense that recollection and familiarity should be closely inter-related. When presented with a test item, subjects must initially rely on some kind of stimulus identification process, like that believed to support familiarity. This stimulus identification process may or may not lead to an episodic retrieval experience. Presumably, the better the stimulus is identified, the better the chances are that it will lead to retrieval. In this way familiarity decisions could support successful recollection. Indeed, Atkinson and Juola (1974) originally argued that recollection and familiarity operated in serial stages. If initial familiarity strength did not signal whether the item was new or old, a more elaborative recollective process was engaged.
Our treatment of the effect of scopolamine on recollection and familiarity leads to a very strong prediction. This approach assumes that scopolamine has a correlated effect on the two components. If we could fit the extended model to individual subjects in a within-subjects design, scopolamine should not affect R. It should, however, have an effect on µ R , as well as on µ O .
Although we rejected the Yonelinas High Threshold model as a quantitative description of the data from the scopolamine group, the present manuscript provides some of the strongest evidence to date for the most basic assumptions underlying the Yonelinas model. A great deal of evidence has led to unanimity amongst the memory modeling community that the distribution of memory strengths associated with old items is effectively more variable than the distribution of strengths associated with new items (Ratcliff, Sheu, & Gronlund, 1992; Ratcliff, McKoon, & Tindall, 1994; Shiffrin & Steyvers, 1997; Glanzer, Adams, Iverson, & Kim, 1993; McClelland & Chappell, 1998) . 3 Yonelinas' original arguments for the High Threshold model hinged on a very specific property of the response distributions. This property 4 could simply be a consequence of a single-process strength distribution that falls off very gradually. However, the old item distribution we observed with administration of scopolamine clearly shows two distinct peaks. This pattern cannot be explained by a unimodal distribution no matter how skewed it might be. A two-process model provides the most parsimonious explanation for a bimodal distribution like the one we observed with scopolamine-injected subjects. We would argue that it is also more parsimonious to assume that the scopolamine data reveals properties of the control data that are not typically observable, rather than assuming that scopolamine gives rise to a completely novel memory process that results in high-confidence 'yes' judgements. There were also hints of a truly bimodal strength distribution for some of the individual control subjects' data (see Figure 3a , lower left). Perhaps this pattern could be consistently evoked with control subjects with suitable methodological changes.
Conclusions
We studied recognition memory for complex visual pictures in subjects administered scopolamine and control subjects. Subjects responded with one of five confidence ratings. Although the distribution of responses to new items was the same for each group, there was a clear difference between the response distributions to old items, indicating an effect of scopolamine on item recognition memory. Although the old item response distributions from the scopolamine-injected subjects could not be fit by the Yonelinas High Threshold model (Yonelinas, 1994 (Yonelinas, , 1999 , they were well-fit by a simple extension of this model that assumes that recollection is variable. The bimodal response distributions obtained for scopolamine-injected subjects constitute strong evidence that two processes underlie item recognition, supporting the central thesis of the Yonelinas High Threshold model. Rather than finding a dissociation between recollection and familiarity, as we expected a priori, we were able to model the effect of scopolamine by assuming that it had exactly the same effect on recollection and familiarity.
